PMID: 6978294Jan 1, 1981Paper

Ventricular arrhythmia before and after aorto-coronary bypass surgery

International Journal of Cardiology
N de SoyzaJ E Doherty

Abstract

The influence of aorto-coronary bypass surgery (ACBS) on ventricular arrhythmia was examined in 57 patients. Six-hour Holter monitoring was done on the day prior to and 3 mth after ACBS. None of the patients were on any antiarrhythmic drugs during these recordings. Ventricular arrhythmia was classified into three groups: Group I (45 patients) had an average of less than 10 premature ventricular contractions (PVCs) per hour, Group II (7 patients), 11-30 PVCs per hour and Group III (5 patients), greater than 30 PVCs per hour. There was no significant change in the number of patients in each group after ACBS. Complex PVCs were present in 8 patients preoperatively and in 9 patients after ACBS. The number of diseased vessels and the extent of left ventricular wall motion abnormality noted preoperatively, had no effect on ventricular arrhythmia following surgery. These data show that ACBS, when performed to relieve angina, does not have a significant effect on the prevalence of PVCs and does not prevent or reduce the occurrence of complex PVCs.

References

Jul 1, 1978·Annals of Internal Medicine·N de SoyzaJ E Doherty
Jul 1, 1979·American Heart Journal·F LeuteneggerD Burckhardt

❮ Previous
Next ❯

Citations

May 1, 1988·The American Journal of Cardiology·J BorbolaP Denes
Jan 1, 1986·The American Journal of Cardiology·E J TopolL S Griffith
Sep 1, 1983·Clinical Cardiology·K P Anderson, J W Mason
Mar 19, 2011·Skinmed·Naili MaW Clark Lambert
Aug 1, 1990·Biological Reviews of the Cambridge Philosophical Society·M M Smith, B K Hall
Jan 8, 2013·Toxicology and Industrial Health·Taofeek O AjiboyeSimiat M Ogunbode
Nov 30, 1999·The International Journal of Angiology : Official Publication of the International College of Angiology, Inc·H ParikkaM S Nieminen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.